The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells
LEUKEMIA (2016)
期刊
LEUKEMIA
卷 30, 期 2, 页码 337-345出版社
NATURE PUBLISHING GROUP
关键词
资金
- Dutch Cancer Society Clinical Fellowship
作者
我是这篇论文的作者
推荐
Nucleosome repositioning in chronic lymphocytic leukemia
Kristan V. Piroeva, Charlotte Mcdonald, Charalampos Xanthopoulos, Chelsea Fox, Christopher T. Clarkson, Jan-Philipp Mallm, Yevhen Vainshtein, Luminita Ruje, Lara C. Klett, Stephan Stilgenbauer, Daniel Mertens, Efterpi Kostareli, Karsten Rippe, Vladimir B. Teif
GENOME RESEARCH (2023)
Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?
Ebru Aydin, Sebastian Faehling, Mariam Saleh, Laura Llao Cid, Martina Seiffert, Philipp M. Roessner
FRONTIERS IN IMMUNOLOGY (2021)
Exploring the pathways to chronic lymphocytic leukemia
Freda K. Stevenson, Francesco Forconi, Thomas J. Kipps
BLOOD (2021)
Prediction and pan-cancer analysis of mammalian transcripts involved in target directed miRNA degradation
Ines Simeone, Carmela Rubolino, Teresa Maria Rosaria Noviello, Diego Farinello, Luigi Cerulo, Matteo Jacopo Marzi, Francesco Nicassio
NUCLEIC ACIDS RESEARCH (2022)
Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy
Nozomi Igarashi, Megumi Honjo, Makoto Aihara
EXPERIMENTAL EYE RESEARCH (2021)
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors
Andrej Besse, Marianne Kraus, Max Mendez-Lopez, Elmer Maurits, Herman S. Overkleeft, Christoph Driessen, Lenka Besse
CELLS (2022)
Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo
Ecem Sevim, Salma Siddique, Madhavi Latha S. Chalasani, Susan Chyou, William D. Shipman, Orla O'Shea, Joanna Harp, Oral Alpan, Stephane Zuily, Theresa T. Lu, Doruk Erkan
JOURNAL OF RHEUMATOLOGY (2022)
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
Clare Sun, Chen Yun-Ching, Aina Martinez Zurita, Maria Joao Baptista, Stefania Pittaluga, Delong Liu, Daniel Rosebrock, Satyen Harish Gohil, Nakhle S. Saba, Theresa Davies-Hill, Sarah E. M. Herman, Gad Getz, Mehdi Pirooznia, Catherine J. Wu, Adrian Wiestner
BLOOD ADVANCES (2023)
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
Katharina Joechle, Jessica Guenzle, Claus Hellerbrand, Pavel Strnad, Thorsten Cramer, Ulf Peter Neumann, Sven Arke Lang
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia
Andres Chang, Anton M. Sholukh, Andreas Wieland, David L. Jaye, Mary Carrington, Meei-Li Huang, Hong Xie, Keith R. Jerome, Pavitra Roychoudhury, Alexander L. Greninger, Jean L. Koff, Jonathon B. Cohen, David M. Koelle, Lawrence Corey, Christopher R. Flowers, Rafi Ahmed
JOURNAL OF CLINICAL INVESTIGATION (2022)
Dual Targeting by Inhibition of Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Attenuates the Neuroinflammatory Responses in Murine Hippocampal Cells and Seizures in C57BL/6 Mice
Preeti Vyas, Rajkumar Tulsawani, Divya Vohora
FRONTIERS IN IMMUNOLOGY (2021)
Sialylation regulates migration in chronic lymphocytic leukemia
Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Ilaria Del Giudice, Roberta Soscia, Nadia Peragine, Stefania Intoppa, Maria Laura Milani, Anna Guarini, Robin Foa
HAEMATOLOGICA (2023)
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia
Andrea N. Mazzarello, Eva Gentner-Goebel, Marcus Duehren-von Minden, Tatyana N. Tarasenko, Antonella Nicolo, Gerardo Ferrer, Stefano Vergani, Yun Liu, Davide Bagnara, Kanti R. Rai, Jan A. Burger, Peter J. McGuire, Palash C. Maity, Hassan Jumaa, Nicholas Chiorazzi
JOURNAL OF CLINICAL INVESTIGATION (2022)
Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jun Zeng, Qiang Zhong, Xiaobing Feng, Linde Li, Shijian Feng, Yu Fan, Turun Song, Zhongli Huang, Xianding Wang, Tao Lin
FRONTIERS IN IMMUNOLOGY (2021)
Homogeneously high expression of CD32b makes it a potential target for CAR-T therapy for chronic lymphocytic leukemia
Guoling Wang, Xiaolei Sun, Shiyu Zuo, Chuo Li, Qing Niu, Yonghui Xia, Yuan Meng, Min Liu, Zihao Fang, Xi Yang, Yanyu Jiang, Sheng Wang, Haidong Cui, Huifang Huang, Erlie Jiang, Dongming Zhou, Qi Deng, Jing Pan, Xiaoming Feng
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Overcoming resistance hurdles
Rachel Thijssen
BLOOD (2022)
Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors
Ella R. Thompson, Tamia Nguyen, Yamuna Kankanige, John F. Markham, Mary Ann Anderson, Sasanka M. Handunnetti, Rachel Thijssen, Paul Sung-Hao Yeh, Constantine S. Tam, John F. Seymour, Andrew W. Roberts, David A. Westerman, Piers Blombery
BLOOD ADVANCES (2022)
A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways
Martin F. M. de Rooij, Yvonne J. Thus, Nathalie Swier, Roderick L. Beijersbergen, Steven T. Pals, Marcel Spaargaren
NATURE COMMUNICATIONS (2022)
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy
Rachel Thijssen, Luyi Tian, Mary Ann Anderson, Christoffer Flensburg, Andrew Jarratt, Alexandra L. Garnham, Jafar S. Jabbari, Hongke Peng, Thomas E. Lew, Charis E. Teh, Quentin Gouil, Angela Georgiou, Tania Tan, Tirta M. Djajawi, Constantine S. Tam, John F. Seymour, Piers Blombery, Daniel H. D. Gray, Ian J. Majewski, Matthew E. Ritchie, Andrew W. Roberts, David C. S. Huang
BLOOD (2022)
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Yvonne J. Thus, Eric Eldering, Arnon P. Kater, Marcel Spaargaren
LEUKEMIA (2022)
RUV-III-NB: normalization of single cell RNA-seq data
Agus Salim, Ramyar Molania, Jianan Wang, Alysha De Livera, Rachel Thijssen, Terence P. Speed
NUCLEIC ACIDS RESEARCH (2022)
Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation
Yvonne J. Thus, Martin F. M. de Rooij, Nathalie Swier, Roderick L. Beijersbergen, Jeroen E. J. Guikema, Marie-Jose Kersten, Eric Eldering, Steven T. Pals, Arnon P. Kater, Marcel Spaargaren
HAEMATOLOGICA (2023)
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity
Timon A. Bloedjes, Guus de Wilde, Gerarda H. Khan, Timothy C. Ashby, John D. Shaughnessy Jr, Fenghuang Zhan, Riekelt H. Houtkooper, Richard J. Bende, Carel J. M. van Noesel, Marcel Spaargaren, Jeroen E. J. Guikema
BLOOD ADVANCES (2023)
JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL
Marco V. V. Haselager, Rachel Thijssen, Danique Bax, Demi Both, Francien De Boer, Simon Mackay, Julie Dubois, Clemens Mellink, Arnon P. P. Kater, Eric Eldering
MOLECULAR ONCOLOGY (2023)
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations
Moritz Fuerstenau, Yvonne J. Thus, Sandra Robrecht, Clemens H. M. Mellink, Anne-Marie van der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christof Schneider, Christian Bjoern Poulsen, Thomas Illmer, Bjoern Schoettker, Ann Janssens, Ilse Christiansen, Thomas Noesslinger, Michael Baumann, Holger Hebart, Tobias Gaska, Josien C. Regelink, Ellen C. Dompeling, Vesa Lindstroem, Gunnar Juliusson, Anouk Widmer, Jeroen Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna-Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brueggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten U. Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P. Kater
BLOOD (2023)
MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas
Marthe Minderman, Hildo C. Lantermans, Leonie J. Gruneberg, Saskia A. G. M. Cillessen, Richard J. Bende, Carel J. M. van Noesel, Marie Jose Kersten, Steven T. Pals, Marcel Spaargaren
BLOOD CANCER JOURNAL (2023)
Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies
Francesca Favaro, Demi Both, Ingrid A. M. Derks, Marcel Spaargaren, Cristina Munoz-Pinedo, Eric Eldering
ONCOGENESIS (2023)
An Unbiased CRISPR-Cas9 Screening Method for the Identification of Positive and Negative Regulatory Proteins of Cell Adhesion
Yvonne J. Thus, Martin F. M. de Rooij, Roderick L. Beijersbergen, Marcel Spaargaren
BIO-PROTOCOL (2022)
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
Anne W. J. Martens, Joanne M. Rietveld, Renate de Boer, Fleur S. Peters, An Ngo, Lotte W. H. G. van Mil, Koen de Heer, Marcel Spaargaren, Christie P. M. Verkleij, Niels W. C. J. van de Donk, Homer C. Adams, Eric Eldering, Carel J. M. van Noesel, Raluca Verona, Arnon P. Kater
CANCER RESEARCH COMMUNICATIONS (2022)
Comprehensive characterization of single-cell full-length isoforms in human and mouse with long-read sequencing
Luyi Tian, Jafar S. Jabbari, Rachel Thijssen, Quentin Gouil, Shanika L. Amarasinghe, Oliver Voogd, Hasaru Kariyawasam, Mei R. M. Du, Jakob Schuster, Changqing Wang, Shian Su, Xueyi Dong, Charity W. Law, Alexis Lucattini, Yair David Joseph Prawer, Coralina Collar-Fernandez, Jin D. Chung, Timur Naim, Audrey Chan, Chi Hai Ly, Gordon S. Lynch, James G. Ryall, Casey J. A. Anttila, Hongke Peng, Mary Ann Anderson, Christoffer Flensburg, Ian Majewski, Andrew W. Roberts, David C. S. Huang, Michael B. Clark, Matthew E. Ritchie
GENOME BIOLOGY (2021)